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In the last decade, Chlamydia trachomatis has been recognized as one of the most common sexually transmitted pathogens (2, 5) . Approximately 3 million new chlamydial infections occur annually in the United States (3) . In men, it causes nongonococcal urethritis and epididymitis. In women, it may cause cervicitis, the urethral syndrome, endometritis and salpingitis, or perihepatitis. Many genital infections are asymptomatic. Infants passing through an infected birth canal are at risk of developing inclusion conjunctivitis or pneumonia or both (6) .
Chlamydiae are obligate intracellular parasites which infect and subsequently multiply in columnar epithelial cells. Tissue culture of chlamydiae requires facilities that are not generally available, are costly, and require 3 to 7 days for completion. Thus, the management of chlamydial infections is often presumptive, based on clinical indicators (8) . Presumptive therapy for symptomatic patients, however, does not control the increasing reservoir of asymptomatic women, who are subject to serious complications and who may unknowingly infect sexual partners and neonates. Development of a rapid, inexpensive, sensitive, and specific diagnostic test for C. trachomatis would aid in efforts to control chlamydial infections by detecting the large number of asymptomatic infections in the population.
The MicroTrak Chlamydia trachomatis direct specimen test (Syva Co., Palo Alto, Calif.) has been presented as a rapid alternative method of detecting C. trachomatis infection. The test uses fluorescein-conjugated monoclonal antibodies, reactive with all 15 known human serovars of C. trachomatis, to detect elementary bodies in clinical smears (9, 10) . We compared the fluorescein-conjugated monoclonal * Corresponding author.
antibody (FA) system with TC in diagnosing cervical chlamydial infection in three populations of women.
MATERIALS AND METHODS
Patient population. In this study, clinical specimens were received from three populations of females: (i) asymptomatic females in an adolescent clinic, (ii) asymptomatic females attending a planned parenthood clinic, and (iii) patients with acute salpingitis.
Specimen collection. Duplicate endocervical specimens were collected from women by using a dacron swab for the MicroTrak direct specimen test and a calcium alginate swab for TC. Sampling order was randomized. The exocervix was first cleaned with a cotton or dacron swab to remove mucus and exudate. Another dacron swab was inserted into the endocervical canal, rotated against the wall and removed, avoiding contact with any vaginal surface. The swab was rolled onto the MicroTrak slide, covering the 8-mm well evenly with specimen. The slide was air dried, fixed by flooding with 100% acetone, and air dried again. Fixed slides were stored at 4°C until stained. A calcium alginate swab was collected the same way and then immersed in transport medium (2.0 ml of Eagle minimal essential medium in Earle salts containing 10% fetal calf serum, 1% L-glutamine [200 nM solution], 10 ,ug of gentamycin per ml, 100 ,ug of vancomycin per ml, 10 U of mycostatin per ml, and 3 ,uM glucose per ml) for culture. Specimens were stored at 4°C for up to 72 h before inoculation of cells.
MicroTrak procedure. The MicroTrak reagent contains fluorescein-conjuated monoclonal antibodies against the chlamydial major outer membrane protein and a counterstain (Evan blue) in a protein-stabilized buffer solu- (12 V, 100 W), and a filter system for fluorescein isothiocyanate examination. Patient and control slides were screened at x400 magnification, and all positive slides were confirmed at x1,000 magnification. Every field within the well was scanned. Slides were scored as positive only when 10 or more smooth, evenly fluorescing, bright apple-green disks consistent with chlamydial elementary bodies were seen. Negative slides contained fewer than 10 fluorescing chlamydial particles per well. All slides were graded as follows: 0, no particles seen; 1, <10 particles; 2, 10 to 25 particles; 3, >25 particles seen per slide. Thin acellular smears containing only squamous cells or polymorphonuclear leukocytes indicated that an inadequate specimen had been collected, and specimen pairs producing such smears were excluded from analysis.
TC. Chlamydia TC tests were carried out in cycloheximide-treated McCoy cells in 1-dram (ca. 4-g) shell vials by using a modification of the procedure of Ripa and M?ardh (4). Inocula were centrifuged onto the monolayers (2,700 x g for 1 h). After incubation at 35°C under 5% CO, for 3 days, one vial of each specimen was fixed with methanol and stained with iodine. Cover slips were removed from the vials and examined microscopically for intracytoplasmic inclusions of C. trcachornatis. Four days after first passage, the two remaining vials were pooled for a second (blind) passage, which was done in the same manner. Cultures were graded as follows: 0, negative culture; 1, <25 inclusions; 2, 25 to 100 inclusions; 3, >100 inclusions per cover slip.
Statistical comparisons. Sensitivity, specificity, and predictive values were calculated by using standard techniques (1). Another potential cause of false-positive FA results is the cross-reaction of antigen in the specimen. The assumption that because the reagent is a monoclonal antibody it will only stain C. trachomatis is wrong. We have seen three different bacteria fluoresce in this test. The morphology is more likely to be confused with reticulate bodies than with elementary bodies, but that statement is based on slides for which we could make the differentiation, not on slides that we misidentified and thus reported as false-positive results. There is a subjective element associated with reading the direct immunofluorescence test, and a careful program of training and standardization is required for proper interpretation of this test.
RESULTS
Our results suggest that the MicroTrak test would be useful for diagnosing chlamydial infection in high-prevalence populations. For low-risk groups, however, our results suggest that the predictive value of a positive test would be low. For example, projection of our results (sensitivity, 70%; specificity, 94%) onto a population of 1,000 women with a 5% prevalence of chlamydial infection would result in correct identification of 35 of the 50 infected women, falsenegative results for 15 women ( smears. The fatigue factor in the reliability of microscopic evaluation, as well as the reluctance of technicians to spend that much time at that task, would also have to be considered.
In summary, the FA procedure has a performance profile which could make it a useful tool in screening high-risk populations (particularly when tissue culture is not available), but it is less suited to screening low-risk populations, for which false-positive results are more important.
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ADDENDUM
After this manuscript was submitted, we initiated an evaluation of the FA test in a clinic for sexually transmitted disease. One hundred ninety-two paired specimens were collected. Of these, 7 were not evaluable due to cytopathic effect in tissue culture, and 13 slides were inadequate. The 7% rate of inadequate smears was lower than that observed in the previous screening studies and probably reflects the greater specimen-collecting expertise of the sexually transmitted disease clinic personnel. The results are shown in Table 4 . With a prevalence of 20% (34/172), the FA test was still less sensitive than TC, being positive in only 76% (26/34) of the specimens in which TC was positive. Specificity of the test was 96% (133/138). Thus, the overall performance profile was similar to that which we had observed before, but because of higher prevalence, the predictive value of a positive FA test was 84% (26/31), and that result, combined with the greater 
